<DOC>
	<DOC>NCT00159328</DOC>
	<brief_summary>The purpose of this study is to determine whether ablation of uterine fibroids with MR guided focused ultrasound following 3 months pre-treatment with Gonadotrophin releasing analogues will allow the effective use of this therapy in women with larger fibroids.</brief_summary>
	<brief_title>Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Subject has given consent Willing and able to attend all visits Minimum age 18 with no desire for future fertility Uterine fibroid &gt; 300 cc on MRI Normal cervical smear Screening symptom score &gt;21 Pre or perimenopausal Fibroids being device accessible Pregnancy Previous GNRH treatment HRT use Hormonal Contraception Patient on dialysis Haematocrit &lt;25 ASA score &gt; 2 Severe cerebrovascular disease Anticoagulated Active pelvic infection or history of PID Weight&gt; 250 lbs Any contraindication to MR imaging Intolerance to MRI contrast agent Unable to remain in prone positions for 3hours IUCD Abdominal scarring in beam pathway Breast feeding Nonperfused fibroid on contrast enhanced images</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Magnetic Resonance Guided Focused Ultrasound</keyword>
	<keyword>Gonadotrophin Releasing Hormone Agonist</keyword>
	<keyword>Uterine Fibroids</keyword>
</DOC>